See also this year's filing and all EDGAR filings for this company.
PDF Report 0001347242_2024_Lipella_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001347242, Lipella Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,429,280 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,750 |
| 3 | remainder_Assets | 135,144 |
| 4 | LiabilitiesCurrent | 385,355 |
| 5 | LiabilitiesNoncurrent | 47,371 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,156,734 |
| 9 | ResearchAndDevelopmentExpense | 3,038,836 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 449,617 |
| 12 | remainder_NetIncome | 126,988 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,577,174 |
| 1 | Liabilities | 432,726 |
| 2 | Expenses | 5,195,570 |
| 3 | Revenues | 449,617 |
| 4 | StockholdersEquity | 3,144,448 |
| 5 | NetIncome | -4,618,965 |
| 6 | ComprehensiveNetIncome | -4,618,965 |
| 7 | BaseVar | 4,891,038 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.12 |
| 9 | EconomicCapitalRatio | 2.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
